Welcome to the UCL Cancer Institute
The UCL Cancer Institute is the hub for cancer research at University College London, one of the World's leading universities. The Institute draws together over 300 talented scientists who are working together to translate research discoveries into developing better, more effective therapies for cancers and improve outcomes for cancer patients. If you are thinking about postgraduate study with us, applications to our flagship MSc Cancer programme are now open for the academic year 2017/18, or find our more about our postgraduate research.
News and features
His Royal Highness The Duke of Kent visited laboratories at University College London (UCL) today to hear about a cutting-edge research project looking at ways to overcome treatment resistance in the most common form of childhood leukaemia.
Published: Feb 1, 2017 5:03:05 PM
A new test for bladder cancer could enable GPs to test a urine sample and spare patients the discomfort of a cystoscopy in hospital, according to research published today in Clinical Epigenetics.
Published: Jan 31, 2017 2:52:42 PM
A research team, led by UCL, has published the results of a highly anticipated clinical trial comparing platinum and non-platinum chemotherapy in the Journal of Clinical Oncology. The aim of this trial was to see whether doctors could select the most effective chemotherapy treatment for advanced lung cancer patients.
Published: Jan 13, 2017 12:07:27 PM
A new non-surgical treatment for early, low-risk prostate cancer can effectively kill cancer cells while preserving healthy tissue, reports a new phase III clinical trial in 413 patients led by Professor Mark Emberton, Dean of UCL Medical Sciences and consultant urologist at UCLH. The trial was funded by STEBA Biotech which holds the commercial license for the treatment.
Published: Dec 20, 2016 10:16:16 AM
Support our work
Help us to continue the research that will lead to the breakthroughs in cancer therapies that will benefit the lives of cancer patients.